Abstract:Key Points Mitochondria are essential for neuronal function and survival. Mitochondria are commonly found in synaptic terminals, where they help to maintain neurotransmission by producing ATP and buffering Ca 2+ . Mitochondrial transport and distribution in neurons is efficiently regulated in response to changes in neuronal activity and various physiological and pathological states. Neuronal mitochondria undergo dynamic and bidirectional transport along neuronal processes, frequently changing direction, pausing or switching to persistent docking. These complex mitochondrial mobility patterns are a result of mitochondrial coupling to anterograde kinesin motors of the KIF5 family and to the retrograde motor dynein, as well as to docking and anchoring machineries, including syntaphilin. Mitochondria attach to the motors by associating with their respective motor adaptor proteins and mitochondrial receptors. These motor–adaptor–receptor complexes ensure targeted trafficking of mitochondria and precise regulation of their mobility. The KIF5–Milton–MIRO complex constitutes a mitochondrial transport machinery, through which a MIRO Ca 2+ -sensing pathway mediates the suppression of mitochondrial mobility in response to increased action potential firing rates or the activation of glutamate receptors. Syntaphilin acts as a 'static anchor' for axonal mitochondria. Deleting the syntaphilin gene resulted in a robust increase in the percentage of mobile axonal mitochondria relative to wild-type neurons. Elaborate mitochondrial quality-control systems maintain mitochondrial integrity and function. These include transport, fusion, fission and turnover via mitophagy and constitute an interdependent system of mitochondrial dynamics. It is well documented that mitochondrial dysfunction, changes in mitochondrial dynamics and mobility, and perturbation of mitochondrial turnover are involved in the pathology of some major neurodegenerative and neurological disorders. Identification of the molecules involved in linking mitochondrial transport, fusion, fission and mitophagy will advance our understanding of the cellular mechanisms that regulate mitochondrial quality control and thus human neurodegenerative diseases.

The Role of PGC-1α-Mediated Mitochondrial Biogenesis in Neurons

Deregulation of Mitochondrial Fusion and Fission in Neurodegenerative Diseases

Deciphering the role of PGC-1α in neurological disorders: from mitochondrial dysfunction to synaptic failure

Metabolic Regulation of Mitochondrial Protein Biogenesis from a Neuronal Perspective

PGC-1α Sparks the Fire of Neuroprotection Against Neurodegenerative Disorders.

Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target

Programming Axonal Mitochondrial Maintenance and Bioenergetics in Neurodegeneration and Regeneration

PGC-1a mediated mitochondrial biogenesis promotes recovery and survival of neuronal cells from cellular degeneration

Neuronal Mitochondrial Transport and Turnover Via Mitophagy

Mitochondria in Neurogenesis: Implications for Mitochondrial Diseases

Mechanism of PGC-1α-mediated mitochondrial biogenesis in cerebral ischemia–reperfusion injury

Role of PGC-1α in the Mitochondrial NAD+ Pool in Metabolic Diseases

Roles of Oxidative Stress, Apoptosis, PGC-1α and Mitochondrial Biogenesis in Cerebral Ischemia

The Interaction of Mitochondrial Biogenesis and Fission/Fusion Mediated by PGC-1α Regulates Rotenone-Induced Dopaminergic Neurotoxicity

The Interplay of Axonal Energy Homeostasis and Mitochondrial Trafficking and Anchoring

The potential benefits of PGC-1α in treating Alzheimer's disease are dependent on the integrity of the LLKYL L3 motif: Effect of regulating mitochondrial axonal transportation

Pgc-1 Beta-Regulated Mitochondrial Biogenesis and Function in Myotubes is Mediated by Nrf-1 and Err Alpha

Mitostasis, Calcium and Free Radicals in Health, Aging and Neurodegeneration

Regulation of Mitochondrial Transport in Neurons.

Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration

Mitochondrial Protein PGAM5 Emerges as a New Regulator in Neurological Diseases